Julie Morgan

It also said the workforce reduction is a central component of Project Imagine, a strategic initiative launched in January under Disney's newly appointed chief marketing officer.

The program seeks to consolidate promotional operations across film, TV, and streaming to address narrowing profit margins and a volatile theatrical market.

Low-cost copies of semaglutide from Novo Nordisk are reshaping India's obesity drug market and cutting into Eli Lilly's early lead.

Within days of generics launching, semaglutide share rose to 33 percent in March from 25 percent.

Terzepatide, which is the active ingredient in Lilly's manjaro, fell to 64 percent from 71 percent, according to PharmaRack.

Lilly will lose exclusivity on the drug in the next decade.

This shift shows how quickly cheaper versions can take market share once patents loosen.

Now for a look at a few other articles that are trending.

OpenAI's CFO says it is planning retail IPO share allocation.

Besant flags urgency on a crypto bill amid gaps in regulation.

And Meta's Muse Spark reportedly trails OpenAI, Google, and Anthropic in early benchmarks.

A couple of items on our catalyst to watch for the day.

Dow will hold its annual meeting.

Shareholders will vote on new directors, a stock incentive plan amendment, and choosing the frequency of future say-on-pay votes.

and a couple of presenters at the J.P.

Morgan Retail Roundup Forum, the CFOs of Walmart and Home Depot.

And on Wall Street, stock index futures are lower before the opening bell, as hopes of a resolution to the U.S.-Iran conflict wane following warnings from President Trump of a major escalation.

Crude oil is up 3.2% at $97, Bitcoin is up 0.5% at $71,000, and gold is up 0.1% at $47.28.

The FTSE 100 is down 0.25%, and the DAX is down 1%.

Applied Digital is on our list of the biggest movers of the day pre-market.